Employee Stock Options (ESOPs) carry a genuinely two-part tax structure that catches many employees off guard, particularly at fast-growing companies where option grants have become a standard part of compensation. Understanding both tax events separately, rather than assuming the entire benefit is taxed once at sale, matters both for cash flow planning and for avoiding an unexpected tax bill.
The First Tax Event: Exercising Your Option
When you exercise an ESOP, converting your option into actual shares by paying the exercise price, the difference between the Fair Market Value (FMV) of the shares at that time and the exercise price you paid is treated as a "perquisite," taxed as part of your salary income in the year of exercise, at your applicable income tax slab rate.
This is the part that surprises many employees: you owe tax on this notional gain the moment you exercise, even if you haven't sold a single share and have no actual cash from the transaction yet. For a private company where shares aren't easily sellable, this can create a genuine cash flow problem, you owe real tax on a paper gain you can't easily convert to cash.
A Worked Example of the Exercise Tax
Say your company granted you options to buy 1,000 shares at an exercise price of ₹50 each. At the time you exercise, the FMV is ₹200 per share. Your taxable perquisite is (₹200 − ₹50) × 1,000 = ₹1,50,000, added to your salary income for that year and taxed at your slab rate, say 30%, meaning roughly ₹45,000 in tax owed, purely from exercising, before you've sold anything.
The Second Tax Event: Selling the Shares
When you eventually sell the shares, the difference between your sale price and the FMV at the time of exercise (which becomes your cost basis for capital gains purposes) is taxed as capital gains, following the standard equity capital gains rules if it's a listed company (LTCG at 12.5% above ₹1.25 lakh if held over 12 months, STCG at 20% if held 12 months or less, as covered in our capital gains tax guide), or the non-equity rules if it's an unlisted company's shares.
Continuing the Example
Following from above, if you later sell those 1,000 shares at ₹350 each, having exercised at an FMV of ₹200, your capital gain is (₹350 − ₹200) × 1,000 = ₹1,50,000. If held over 12 months and the company is listed, this is taxed as LTCG at 12.5% above the ₹1.25 lakh exemption. Notice this is entirely separate from the ₹1,50,000 perquisite already taxed at exercise, you're taxed on the growth from exercise-FMV to sale price, not on the original grant-to-sale gain as a single number.
The Startup-Specific Deferral for Eligible Companies
Recognising the cash flow problem of taxing a paper gain at exercise for illiquid private company shares, the government introduced a deferral mechanism for employees of eligible startups (registered as such with specific conditions). For qualifying startup ESOPs, the perquisite tax at exercise can be deferred, payable instead within a specified period after the earliest of: the shares being sold, the employee leaving the company, or a fixed number of years from exercise. This doesn't eliminate the tax, it defers the payment timing to a point when the employee is more likely to have actual liquidity from selling shares.
What Employees Often Get Wrong
Assuming there's only one tax event (at sale) is the most common and costly misunderstanding, employees who exercise options in a private company without planning for the exercise-time tax liability can face a genuine cash crunch, owing real tax on shares they can't yet sell. Understanding this upfront, and planning the timing of exercise around your ability to pay the resulting tax, or checking whether the startup deferral applies to your specific situation, is worth doing before exercising any meaningful option grant.
Planning Considerations Before Exercising
- Confirm whether your company qualifies for the startup ESOP tax deferral, and if so, understand exactly when the deferred tax becomes due
- Have a clear plan for how you'll pay the exercise-time perquisite tax if no deferral applies, especially for illiquid private company shares
- Understand your cost basis for the eventual capital gains calculation, which is the FMV at exercise, not your original exercise price paid
- Track the holding period from the date of exercise (not the original grant date) for capital gains classification purposes
Frequently Asked Questions
Is the FMV at exercise determined by the company, or an independent valuation?
For unlisted companies, FMV is typically determined by a category I merchant banker's valuation report, a formal, regulated process, not simply a figure the company arbitrarily assigns. For listed companies, FMV is generally based on the market price on the stock exchange at the relevant date.
Does the startup ESOP tax deferral apply to all private companies, or only specific ones?
It applies specifically to companies recognised as "eligible startups" under the government's specific registration criteria, not to every unlisted private company generally, worth confirming your specific employer's status if you're counting on this deferral.
What happens to unexercised ESOPs if I leave the company?
This depends entirely on your company's specific ESOP scheme rules, unexercised options frequently have a limited exercise window after leaving (sometimes 90 days, though this varies considerably), after which unexercised options may lapse entirely, worth checking your specific grant agreement.
Is TDS deducted on the ESOP perquisite the same way as regular salary?
Yes, employers are generally required to deduct TDS on the ESOP perquisite value at the time of exercise (or at the deferred payment point for eligible startup deferrals), treating it as part of your salary income for TDS purposes that year.
